Verona Pharma PLC on Monday said data from Phase 2b trials showed that nebulized ensifentrine improved lung function ...
Subscribe now to see this Premium News article from
Alliance News Professional covers every UK stock in your portfolio. It goes beyond regulatory news and free web services to give your investment decisions an edge over the crowd.
Click for a FREE Trial
  • In The Know - Management and analyst comments that go beyond company announcements.
  • Flash headlines on all 2,400 London-listed companies before the news hits the open web.
  • Broker Ratings - The earliest tip-offs, many before the market opens.
  • Economic data and central bank flashes from UK, US and eurozone.
  • Taking AIM - Up to the minute market commentary on AIM stocks.
  • Over 500 news items per trading day for just £39.60 per month, and cancel at any time.
Try Alliance News FREE for 1 Month
Call us on +44 (0) 203 8794 460 to get started.
Verona Pharma (LSE:VRP)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more Verona Pharma Charts.
Verona Pharma (LSE:VRP)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more Verona Pharma Charts.